Purchase Order 36C25626P0031
- Not listed
- Euroimmun US Incorporated, a subsidiary of Revvity Inc., has been awarded a delivery order valued at $54,395.60 under a Blanket Purchase Agreement with the Veterans Integrated Service Network 2 for T-SPOT TB reagents and test kits. The award, made on October 1, 2024, is a firm fixed-price contract with an ultimate completion date of September 30, 2025, and will be performed in Mountain Lakes, New Jersey. This contract does not utilize a set-aside designation, indicating it was awarded through...
- This federal contract award from the Veterans Integrated Service Network 2, part of the Department of Veterans Affairs, is for T-SPOT TB reagents and related services. The $69,125.80 firm-fixed-price contract was awarded to Euroimmun US Incorporated, a wholly owned subsidiary of PerkinElmer that manufactures medical diagnostics, with no set-aside designation. The contract has an ultimate completion date of September 30, 2024. Euroimmun has received previous federal contract awards from HHS...
- This federal contract award is for T-SPOT TB reagents, which are tuberculosis screening products, under a Blanket Purchase Agreement (BPA) with the Department of Veterans Affairs Veterans Integrated Service Network 2. The prime contractor is Euroimmun US Incorporated, a wholly owned subsidiary of Revvity Inc. (formerly PerkinElmer) that specializes in medical diagnostics and laboratory testing equipment. The contract has a ceiling value of $50,031.40 and a firm fixed-price structure. It does not...
- This federal contract award, valued at $23,764.50, was made by the Department of Veterans Affairs (VA) to Euroimmun US Incorporated, a subsidiary of PerkinElmer, for the provision of T-SPOT TB reagents. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price. Euroimmun US Incorporated is the prime contractor on this award, which does not have a set-aside designation. The parent company of the prime contractor is Revvity Inc., which has separately received federal awards...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs to Euroimmun US Incorporated, a subsidiary of Revvity Inc., to provide preventative and corrective maintenance/repair services for the EUROIMMUN IF Sprinter and EUROPATTERN 1.5 microscope equipment used at the Edward Hines, Jr. VA Hospital in Hines, Illinois. The contract has a ceiling value of $109,252.50 and a completion date of September 30, 2026. It was awarded on a sole-source basis without any...
- This is a federal contract awarded by the Department of the Army to Euroimmun US Incorporated, a wholly owned subsidiary of Revvity Inc., to provide medical supplies. The contract has a ceiling value of $20,957 and a completion date of September 30, 2024. Euroimmun US Incorporated has previously received federal contract awards from various Department of Health and Human Services agencies and the Department of Veterans Affairs to supply medical testing equipment, SARS-CoV-2 antibody test kits,...
- This is a firm-fixed-price blanket purchase agreement (BPA) call contract awarded by the Veterans Health Administration (VHA) of the Department of Veterans Affairs to Oxford Immunotec USA, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC. The contract is for the delivery of T SPOT.TB reagents, an FDA-approved tuberculosis diagnostic test, to the VHA's Veterans Integrated Service Network 2 (VISN 2) covering the New England region. The contract has a ceiling value of $128,337.80 and a...
- The Department of Veterans Affairs (VA) awarded a $381,240.30 firm-fixed-price definitive contract to Quest Diagnostics TB LLC, a for-profit manufacturer, to provide TSPOT TB Tests. The contract has a completion date of August 31, 2020 and was set aside for small businesses. The TSPOT TB Tests are being provided to the VA's Veterans Integrated Service Network 17 located in El Paso, TX to support the agency's medical facilities and testing needs. This contract award is part of the VA's broader...
- This is a firm-fixed-price delivery order awarded by the Veterans Integrated Service Network 16 (VISN 16) of the U.S. Department of Veterans Affairs (VA) to Quest Diagnostics Incorporated, a large, for-profit diagnostic information services provider. The contract, worth $75,225.00, is for the provision of T-SPOT TB testing services in support of Executive Order 14042. The contract has an ultimate completion date of July 31, 2026 and is not set aside. Quest Diagnostics has secured numerous...
- This is a delivery order awarded by the Veterans Integrated Service Network 16 (VISN 16), a component of the U.S. Department of Veterans Affairs (VA), to Quest Diagnostics Incorporated for T-SPOT.TB testing services. The contract has a ceiling value of $81,794.65 and a period of performance ending on September 30, 2022. The contract is not set aside and is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). Quest Diagnostics, a for-profit...
Euroimmun US Incorporated, a subsidiary of Revvity Inc., was awarded a $53,847 firm fixed-price purchase order by the Veterans Integrated Service Network 16 (VISN 16) on October 27, 2025, for T-SPOT testing products and services. The contract, which extends through October 26, 2026, will be performed at the contractor's facility in Mountain Lakes, New Jersey. This award was made through open competition with no set-aside designation and represents a continuation of Euroimmun's established role as a supplier of immunodiagnostic testing solutions to the Department of Veterans Affairs. The T-SPOT test is an interferon-gamma release assay used primarily for tuberculosis screening and diagnosis in clinical settings. This purchase order aligns with Euroimmun's broader federal contract portfolio, which includes a $1.1 million Blanket Purchase Agreement with Veterans Integrated Service Network 2 for T-SPOT TB reagents running through September 2026, as well as a $2.4 million Indefinite Delivery Contract with the Department of the Army Medical Command for immunodiagnostic systems reagents. The award demonstrates the VA's continued reliance on Euroimmun's specialized diagnostic capabilities to support preventative healthcare and screening initiatives across its medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.8k | 10/27/25 |